Drug Profile
Hepatitis A-hepatitis B vaccine - Beijing Minhai Biotechnology
Alternative Names: Hepatitis A and B vaccine - Beijing Minhai BiotechnologyLatest Information Update: 28 Jan 2018
Price :
$50
*
At a glance
- Originator Beijing Minhai Biotechnology
- Class Hepatitis A vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis A; Hepatitis B
Most Recent Events
- 28 Jan 2018 No recent reports of development identified for phase-I development in Hepatitis-A(Prevention) in China (Parenteral, Injection)
- 28 Jan 2018 No recent reports of development identified for phase-I development in Hepatitis-B(Prevention) in China (Parenteral, Injection)